The conversation surrounding vaginal health has undergone a dramatic transformation in recent years, moving from the shadows of obscurity into the spotlight of mainstream discourse. This shift has been punctuated by high-profile endorsements, such as billionaire Bryan Johnson celebrating his girlfriend’s vaginal microbiome test results, which he claimed placed her in the top 1% of all vaginas. This public revealing, while perhaps cringe-inducing to some, signals a significant change in how society perceives and talks about women’s health.
The Surge in Investment
In tandem with this cultural shift, investors are recognizing the potential in the burgeoning field of vaginal health. Startups are emerging with innovative solutions focused on vaginal diagnostics, microbiome testing, and reproductive health. One standout is Evvy, based in New York, which has raised over $20 million since its launch five years ago. The company has already served more than 100,000 patients with its at-home vaginal microbiome testing services. Similarly, Dutch startup Yon E Health has initiated funding for a device to measure vaginal pH and temperature, while LiviWell in the U.S. recently secured $3.3 million to enhance vaginal microbiome health. In 2025 alone, women’s health companies attracted a staggering $1.55 billion in equity investment, reflecting a 41% increase from the previous year.
A New Era of Open Dialogue
Platforms like TikTok and Reddit are becoming bustling hubs for discussions about vaginal health, where users share experiences and seek advice on issues ranging from bacterial vaginosis to vaginal hygiene. A study showed that 164 TikTok videos concerning vulvovaginal health garnered over 500 million views, indicating a strong interest in these topics. According to Alice Crossley, a principal strategic foresight analyst, the exploration of longevity is pushing the health wellness industry to examine all aspects of the body, including the vaginal microbiome, which has long been neglected.
Breaking Down Barriers
For decades, research into women’s health has been sidelined, often overshadowed by male-centered studies. Women experience aging differently, yet their unique biological and hormonal distinctions have frequently been treated as secondary. Innovators like Marina Gerner and Dr. Somi Javaid are working to dismantle these stigmas, empowering women to take charge of their health. A recent poll revealed that nearly half of women are prioritizing hormonal health in their wellness routines.
The Complexity of Vaginal Health
Despite the newfound focus, the concept of a “top 1% vagina” raises deeper concerns about commodifying health. As vaginal health becomes a status symbol for those who can afford it, questions arise about who has access to quality care. Historically, intimate care revolved around basic cleansing, evolving into beauty-oriented products. However, a new wave of companies is transforming this landscape into a more sophisticated realm of health-focused solutions.
Pioneering Solutions
Evvy exemplifies this evolution by providing at-home vaginal microbiome testing. Users send in samples analyzed through metagenomic sequencing, which examines all microbes present rather than a predefined list. This approach allows for personalized treatment recommendations. The test costs $159, with a discounted price of $129 for members. Priyanka Jain, Evvy’s CEO, emphasizes that the company was founded to fill significant gaps in women’s healthcare, particularly in understanding female-specific biology.
Addressing the Stigma
The neglect of vaginal health can be attributed to persistent stigma and a lack of research, creating a vicious cycle. Vaginal symptoms have historically been shrouded in shame, influencing both research focus and clinical training. Jain points out that until 1993, women were not required to be included in U.S. clinical research, leading to a medical landscape that inadequately represented female biology.
Innovative Approaches
Daye, another player in this space, is developing a diagnostic tampon that collects vaginal fluid for testing. This method offers a broader sample than traditional swabs and aims to test for various markers related to vaginal health. Valentina Milanova, CEO of Daye, notes that women are becoming increasingly aware of the gaps in their healthcare and are beginning to demand more thorough investigations into their symptoms.
Moving Beyond Diagnostics
Beyond diagnostics, new products are emerging that aim to support the vaginal microbiome directly. Companies like Seed have created vaginal synbiotics, while Vaginal Biome Science is focused on developing therapies to restore vaginal health. However, the perception of these products as luxury items could hinder their scalability and accessibility.
The Need for Inclusivity
Accessibility is essential for the success of these innovations. Daye has prioritized inclusivity in product design, testing their tampon with diverse groups to ensure it meets various needs. The goal is to create diagnostics that are not only effective but also accessible to everyone, not just those with disposable income for luxury health products.
Conclusion: A Health Revolution
The burgeoning interest in vaginal health presents an opportunity to correct historical oversights and empower women. The focus should not be on creating insecurities to monetize but on providing genuine healthcare solutions. As the industry evolves, the emphasis must remain on education, accessibility, and fostering a culture where women can advocate for their own health without stigma. This transformation could lead to a future where women are not only informed but also empowered to embrace their health with confidence.
Key Takeaways
- The vaginal health sector is gaining traction with significant investment and innovation.
- Startups like Evvy and Daye are pioneering solutions that prioritize women’s healthcare.
- Cultural shifts are fostering open discussions about vaginal health across social media platforms.
- Accessibility and inclusivity are critical for the success of vaginal health products.
- The focus should remain on genuine healthcare rather than commodifying insecurities.
Read more → www.vogue.com